|
Phenotypic Information (metabolism pathway, cancer, disease, phenome) | |
Gene-Gene Network Information: Co-Expression Network, Interacting Genes & KEGG | |
Gene Summary for HSD11B1 |
Top |
Phenotypic Information for HSD11B1(metabolism pathway, cancer, disease, phenome) |
Cancer Description | |
Cancer | CGAP: HSD11B1 |
Familial Cancer Database: HSD11B1 |
* This gene is included in those cancer gene databases. |
. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Oncogene 1 | Significant driver gene in |
cf) number; DB name 1 Oncogene; http://nar.oxfordjournals.org/content/35/suppl_1/D721.long, 2 Tumor Suppressor gene; https://bioinfo.uth.edu/TSGene/, 3 Cancer Gene Census; http://www.nature.com/nrc/journal/v4/n3/abs/nrc1299.html, 4 CancerGenes; http://nar.oxfordjournals.org/content/35/suppl_1/D721.long, 5 Network of Cancer Gene; http://ncg.kcl.ac.uk/index.php, 1Therapeutic Vulnerabilities in Cancer; http://cbio.mskcc.org/cancergenomics/statius/ |
Metabolic Pathway Description | |
REACTOME_METABOLISM_OF_STEROID_HORMONES_AND_VITAMINS_A_AND_D REACTOME_METABOLISM_OF_LIPIDS_AND_LIPOPROTEINS |
Mutations for HSD11B1 |
* Under tables are showing count per each tissue to give us broad intuition about tissue specific mutation patterns.You can go to the detailed page for each mutation database's web site. |
Structural Variants in COSMIC: go to COSMIC mutation histogram |
There's no structural variation information in COSMIC data for this gene. |
Related fusion transcripts : go to Chitars2.0 |
* From mRNA Sanger sequences, Chitars2.0 arranged chimeric transcripts. This table shows HSD11B1 related fusion information. |
ID | Head Gene | Tail Gene | Accession | Gene_a | qStart_a | qEnd_a | Chromosome_a | tStart_a | tEnd_a | Gene_a | qStart_a | qEnd_a | Chromosome_a | tStart_a | tEnd_a |
BG954179 | HNRNPH3 | 1 | 264 | 10 | 70098340 | 70099312 | HSD11B1 | 253 | 272 | 1 | 209897701 | 209897720 |
Other DBs for Structural Variants |
Top |
Copy Number Variations in COSMIC: go to COSMIC mutation CNV/Expr |
Mutation type/ Tissue ID | brca | cns | cerv | endome | haematopo | kidn | Lintest | liver | lung | ns | ovary | pancre | prost | skin | stoma | thyro | urina | |||
Total # sample | 2 | 1 |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   | |||
GAIN (# sample) | 2 |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   | |||
LOSS (# sample) |   | 1 |   |   |   |   |   |   |   |   |   |   |   |   |   |   |   |
cf) Tissue ID; Tissue type (1; Breast, 2; Central_nervous_system, 3; Cervix, 4; Endometrium, 5; Haematopoietic_and_lymphoid_tissue, 6; Kidney, 7; Large_intestine, 8; Liver, 9; Lung, 10; NS, 11; Ovary, 12; Pancreas, 13; Prostate, 14; Skin, 15; Stomach, 16; Thyroid, 17; Urinary_tract) |
Top |
SNV Counts per Each Loci in COSMIC data: go to COSMIC point mutation |
|
Top |
Somatic Mutation Counts per Tissue in COSMIC data |
Stat. for Non-Synonymous SNVs (# total SNVs=26) | (# total SNVs=9) |
(# total SNVs=1) | (# total SNVs=0) |
Top |
Top 10 SNVs Having the Most Samples in COSMIC data |
* When you move the cursor on each content, you can see more deailed mutation information on the Tooltip. Those are primary_site,primary_histology,mutation(aa),pubmedID. |
GRCh37 position | Mutation(aa) | Unique sampleID count |
chr1:209879201-209879201 | p.G45V | 3 |
chr1:209879200-209879200 | p.G45R | 2 |
chr1:209880400-209880400 | p.V148V | 2 |
chr1:209907741-209907741 | p.R252C | 2 |
chr1:209879205-209879205 | p.I46I | 2 |
chr1:209879272-209879272 | p.E69K | 2 |
chr1:209880344-209880344 | p.H130Y | 2 |
chr1:209879168-209879168 | p.G34E | 2 |
chr1:209880129-209880129 | p.A99T | 2 |
chr1:209907730-209907730 | p.G248E | 1 |
Top |
SNV Counts per Each Loci in TCGA data |
|
Point Mutation/ Tissue ID | 1 | 2 | 3 | 4 | 5 | 6 | 7 | 8 | 9 | 10 | 11 | 12 | 13 | 14 | 15 | 16 | 17 | 18 | 19 | 20 |
# sample |   | 2 |   | 2 | 1 |   |   |   | 2 |   |   | 2 | 3 |   |   |   | 12 | 3 |   | 7 |
# mutation |   | 2 |   | 2 | 1 |   |   |   | 2 |   |   | 2 | 3 |   |   |   | 11 | 3 |   | 7 |
nonsynonymous SNV |   | 2 |   | 2 | 1 |   |   |   |   |   |   | 1 | 3 |   |   |   | 10 | 3 |   | 4 |
synonymous SNV |   |   |   |   |   |   |   |   | 2 |   |   | 1 |   |   |   |   | 1 |   |   | 3 |
cf) Tissue ID; Tissue type (1; BLCA[Bladder Urothelial Carcinoma], 2; BRCA[Breast invasive carcinoma], 3; CESC[Cervical squamous cell carcinoma and endocervical adenocarcinoma], 4; COAD[Colon adenocarcinoma], 5; GBM[Glioblastoma multiforme], 6; Glioma Low Grade, 7; HNSC[Head and Neck squamous cell carcinoma], 8; KICH[Kidney Chromophobe], 9; KIRC[Kidney renal clear cell carcinoma], 10; KIRP[Kidney renal papillary cell carcinoma], 11; LAML[Acute Myeloid Leukemia], 12; LUAD[Lung adenocarcinoma], 13; LUSC[Lung squamous cell carcinoma], 14; OV[Ovarian serous cystadenocarcinoma ], 15; PAAD[Pancreatic adenocarcinoma], 16; PRAD[Prostate adenocarcinoma], 17; SKCM[Skin Cutaneous Melanoma], 18:STAD[Stomach adenocarcinoma], 19:THCA[Thyroid carcinoma], 20:UCEC[Uterine Corpus Endometrial Carcinoma]) |
Top |
Top 10 SNVs Having the Most Samples in TCGA data |
* We represented just top 10 SNVs. When you move the cursor on each content, you can see more deailed mutation information on the Tooltip. Those are primary_site, primary_histology, mutation(aa), pubmedID. |
Genomic Position | Mutation(aa) | Unique sampleID count |
chr1:209879272 | p.G45V,HSD11B1 | 2 |
chr1:209879201 | p.E69K,HSD11B1 | 2 |
chr1:209879240 | p.R252C,HSD11B1 | 1 |
chr1:209880344 | p.A99T,HSD11B1 | 1 |
chr1:209907848 | p.L267P,HSD11B1 | 1 |
chr1:209878314 | p.L109F,HSD11B1 | 1 |
chr1:209880366 | p.G112R,HSD11B1 | 1 |
chr1:209878329 | p.D287D,HSD11B1 | 1 |
chr1:209880056 | p.L9L,HSD11B1 | 1 |
chr1:209880398 | p.I117I,HSD11B1 | 1 |
Other DBs for Point Mutations |
Copy Number for HSD11B1 in TCGA |
* Copy number data were extracted from TCGA using R package TCGA-Assembler. The URLs of all public data files on TCGA DCC data server were gathered on Jan-05-2015. Function ProcessCNAData in TCGA-Assembler package was used to obtain gene-level copy number value which is calculated as the average copy number of the genomic region of a gene. |
cf) Tissue ID[Tissue type]: BLCA[Bladder Urothelial Carcinoma], BRCA[Breast invasive carcinoma], CESC[Cervical squamous cell carcinoma and endocervical adenocarcinoma], COAD[Colon adenocarcinoma], GBM[Glioblastoma multiforme], Glioma Low Grade, HNSC[Head and Neck squamous cell carcinoma], KICH[Kidney Chromophobe], KIRC[Kidney renal clear cell carcinoma], KIRP[Kidney renal papillary cell carcinoma], LAML[Acute Myeloid Leukemia], LUAD[Lung adenocarcinoma], LUSC[Lung squamous cell carcinoma], OV[Ovarian serous cystadenocarcinoma ], PAAD[Pancreatic adenocarcinoma], PRAD[Prostate adenocarcinoma], SKCM[Skin Cutaneous Melanoma], STAD[Stomach adenocarcinoma], THCA[Thyroid carcinoma], UCEC[Uterine Corpus Endometrial Carcinoma] |
Top |
Gene Expression for HSD11B1 |
Gene Expression in Cancer Cell-lines (CCLE) |
* CCLE gene expression data were extracted from CCLE_Expression_Entrez_2012-10-18.res: Gene-centric RMA-normalized mRNA expression data. |
Differential Gene Expression in Primary Tumors (TCGA) |
* Normalized gene expression data of RNASeqV2 was extracted from TCGA using R package TCGA-Assembler. The URLs of all public data files on TCGA DCC data server were gathered at Jan-05-2015. Only eight cancer types have enough normal control samples for differential expression analysis. (t test, adjusted p<0.05 (using Benjamini-Hochberg FDR)) |
Top |
CNV vs Gene Expression Plot |
* This plots show the correlation between CNV and gene expression. |
Top |
Gene-Gene Network Information |
Co-Expressed gene's network Plot |
* Co-Expression network figures were drawn using R package igraph. Only the top 20 genes with the highest correlations were shown. Red circle: input gene, orange circle: cell metabolism gene, sky circle: other gene |
AADAC,C1orf141,FOXL2NB,MGARP,CELA2A,CYP11A1,CYP17A1, CYP19A1,FSHR,HSD11B1,HSD3B1,INSL3,KLHL4,LHCGR, MBOAT4,MRO,REG3G,STAR,TCF21,TCF23,TREML5P | BHMT2,CDKN2B,CHRDL1,CRTAP,DOCK11,DPT,GLP2R, GNG2,GNS,HSD11B1,ITGB1,ITIH5,PCOLCE2,PEA15, RASA3,RHOQ,SEMA3G,SPTBN1,SRPX2,STS,UCHL1 | ||||
ABCA6,ACSM5,ADIPOQ,ALPL,MEDAG,C1orf162,CCDC80, CD36,CYP1B1,FMO2,HSD11B1,LBP,LOC339524,LTBP2, MFAP5,MRAP,MSC,PDE1B,SEMA3G,SLITRK4,SPTA1 | TMEM237,ANXA1,ARL13B,CMSS1,CDH19,COPS8,CTPS1, DYNC1LI1,EXOC5,EYA4,FGF10,HSD11B1,IL33,CFAP97, LPAR1,NBN,PRDM5,SEPT2,SPP1,TNFAIP6,UTP11L |
Co-Expressed gene's Protein-protein interaction Network Plot |
* Co-Expression network figures were drawn using R package igraph. Only the top 20 genes with the highest correlations were shown. Red circle: input gene, orange circle: cell metabolism gene, sky circle: other gene |
Top |
Interacting Genes (from Pathway Commons) |
Top |
Pharmacological Information for HSD11B1 |
Cross-referenced pharmacological DB IDs from Uniprot |
DB Category | DB Name | DB's ID and Url link |
Drug-Gene Interaction Network |
* Gene Centered Interaction Network. |
* Drug Centered Interaction Network. |
DrugBank ID | Target Name | Drug Groups | Generic Name | Drug Centered Network | Drug Structure |
DB00157 | hydroxysteroid (11-beta) dehydrogenase 1 | approved; nutraceutical | NADH | ||
DB02329 | hydroxysteroid (11-beta) dehydrogenase 1 | experimental | Carbenoxolone | ||
DB03461 | hydroxysteroid (11-beta) dehydrogenase 1 | experimental | 2'-Monophosphoadenosine 5'-Diphosphoribose | ||
DB03814 | hydroxysteroid (11-beta) dehydrogenase 1 | experimental | 2-(N-Morpholino)-Ethanesulfonic Acid | ||
DB04652 | hydroxysteroid (11-beta) dehydrogenase 1 | experimental | (11-BETA)-11,21-DIHYDROXY-PREGN-4-ENE-3,20-DIONE | ||
DB06992 | hydroxysteroid (11-beta) dehydrogenase 1 | experimental | (3,3-dimethylpiperidin-1-yl)(6-(3-fluoro-4-methylphenyl)pyridin-2-yl)methanone | ||
DB07017 | hydroxysteroid (11-beta) dehydrogenase 1 | experimental | (5S)-2-{[(1S)-1-(4-fluorophenyl)ethyl]amino}-5-(1-hydroxy-1-methylethyl)-5-methyl-1,3-thiazol-4(5H)-one | ||
DB07049 | hydroxysteroid (11-beta) dehydrogenase 1 | experimental | (2R)-1-[(4-tert-butylphenyl)sulfonyl]-2-methyl-4-(4-nitrophenyl)piperazine | ||
DB07056 | hydroxysteroid (11-beta) dehydrogenase 1 | experimental | 2-(6-{[(3-chloro-2-methylphenyl)sulfonyl]amino}pyridin-2-yl)-N,N-diethylacetamide | ||
DB07310 | hydroxysteroid (11-beta) dehydrogenase 1 | experimental | (5S)-2-{[(1S)-1-(2-fluorophenyl)ethyl]amino}-5-methyl-5-(trifluoromethyl)-1,3-thiazol-4(5H)-one | ||
DB07316 | hydroxysteroid (11-beta) dehydrogenase 1 | experimental | N-{1-[(1-carbamoylcyclopropyl)methyl]piperidin-4-yl}-N-cyclopropyl-4-[(1S)-2,2,2-trifluoro-1-hydroxy-1-methylethyl]benzamide | ||
DB07619 | hydroxysteroid (11-beta) dehydrogenase 1 | experimental | N-cyclopropyl-N-(trans-4-pyridin-3-ylcyclohexyl)-4-[(1S)-2,2,2-trifluoro-1-hydroxy-1-methylethyl]benzamide | ||
DB07624 | hydroxysteroid (11-beta) dehydrogenase 1 | experimental | 1-{[(3R)-3-methyl-4-({4-[(1S)-2,2,2-trifluoro-1-hydroxy-1-methylethyl]phenyl}sulfonyl)piperazin-1-yl]methyl}cyclopropanecarboxamide | ||
DB07866 | hydroxysteroid (11-beta) dehydrogenase 1 | experimental | (5S)-2-(cyclooctylamino)-5-methyl-5-propyl-1,3-thiazol-4(5H)-one | ||
DB08277 | hydroxysteroid (11-beta) dehydrogenase 1 | experimental | 2-(2-CHLORO-4-FLUOROPHENOXY)-2-METHYL-N-[(1R,2S,3S,5S,7S)-5-(METHYLSULFONYL)-2-ADAMANTYL]PROPANAMIDE | ||
DB08280 | hydroxysteroid (11-beta) dehydrogenase 1 | experimental | (1S,3R,4S,5S,7S)-4-{[2-(4-METHOXYPHENOXY)-2-METHYLPROPANOYL]AMINO}ADAMANTANE-1-CARBOXAMIDE | ||
DB08771 | hydroxysteroid (11-beta) dehydrogenase 1 | experimental | (5R)-2-[(2-fluorophenyl)amino]-5-(1-methylethyl)-1,3-thiazol-4(5H)-one | ||
DB00741 | hydroxysteroid (11-beta) dehydrogenase 1 | approved | Hydrocortisone | ||
DB01132 | hydroxysteroid (11-beta) dehydrogenase 1 | approved; investigational | Pioglitazone | ||
DB00412 | hydroxysteroid (11-beta) dehydrogenase 1 | approved; investigational | Rosiglitazone | ||
DB00197 | hydroxysteroid (11-beta) dehydrogenase 1 | withdrawn | Troglitazone | ||
DB00635 | hydroxysteroid (11-beta) dehydrogenase 1 | approved | Prednisone |
Top |
Cross referenced IDs for HSD11B1 |
* We obtained these cross-references from Uniprot database. It covers 150 different DBs, 18 categories. http://www.uniprot.org/help/cross_references_section |
Copyright © 2016-Present - The Univsersity of Texas Health Science Center at Houston @ |